Trials / Completed
CompletedNCT02664376
Prevalence of Sarcopenia and Its Geriatric Features
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 834 (actual)
- Sponsor
- Brugmann University Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to determine the prevalence of sarcopenia in a geriatric hospital ward. Sarcopenia is defined by a loss of muscle mass, loss of muscle strength and loss of muscle quality. It is a geriatric syndrome that, to this date, is not systematically tracked in clinical practice. In order to detect sarcopenia, the investigators will use the operational definition proposed by the European Working Group (EWGSOP) involving the measure of three parameters, namely the speed of walking, the muscle strength and the measurement of the muscular mass.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sarcopenia detection | The assessment of sarcopenia is performed according to the recommendations of the EWGSOP (European Working Group on Sarcopenia in Older people). Three measurements are made: * Muscle mass measurement by dual energy X-ray absorptiometry (DEXA). * Walking speed measurement * Hand grip test A diagnosis of sarcopenia is established if the walking speed is inferior to 0.8 m/sec, the muscular strength is low and the muscular mass is low. Data regarding the geriatric characteristics of this sarcopenic population will be collected. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-01-18
- Completion
- 2018-01-18
- First posted
- 2016-01-27
- Last updated
- 2018-01-26
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02664376. Inclusion in this directory is not an endorsement.